[
    {
        "submitter_follow_up_id": "FOLLOW_UP_1",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_1",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Partial remission",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-09",
        "method_of_progression_status": "Imaging (procedure)",
        "anatomic_site_progression_or_recurrence": "C10",
        "recurrence_tumour_staging_system": [
            "St Jude staging system",
            "AJCC 6th edition",
            "AJCC 7th edition"
        ],
        "recurrence_t_category": "TX",
        "recurrence_n_category": "N1a",
        "recurrence_m_category": "M1b(0)",
        "recurrence_stage_group": "Stage 1B"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_2",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_1",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Loco-regional progression",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-06",
        "method_of_progression_status": "Histopathology test (procedure)",
        "anatomic_site_progression_or_recurrence": "C20",
        "recurrence_tumour_staging_system": [
            "AJCC 6th edition",
            "AJCC 8th edition",
            "Ann Arbor staging system"
        ],
        "recurrence_t_category": "TX",
        "recurrence_n_category": "N2mi",
        "recurrence_m_category": "M1e",
        "recurrence_stage_group": "Stage IIIC2"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_3",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_1",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "No evidence of disease",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-05",
        "method_of_progression_status": "Physical examination procedure (procedure)",
        "anatomic_site_progression_or_recurrence": "C14",
        "recurrence_tumour_staging_system": [
            "International Neuroblastoma Staging System"
        ],
        "recurrence_t_category": "T1b(m)",
        "recurrence_n_category": "N4",
        "recurrence_m_category": "M1",
        "recurrence_stage_group": "Stage IIAS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_4",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_2",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Distant progression",
        "relapse_type": "Biochemical progression",
        "date_of_relapse": "2022-02",
        "method_of_progression_status": "Imaging (procedure)",
        "anatomic_site_progression_or_recurrence": "C18",
        "recurrence_tumour_staging_system": [
            "Ann Arbor staging system",
            "SEER staging system"
        ],
        "recurrence_t_category": "T3(m)",
        "recurrence_n_category": "N1a(sn)",
        "recurrence_m_category": "M1d",
        "recurrence_stage_group": "Stage 1"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_5",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_2",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Relapse or recurrence",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-11",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C13",
        "recurrence_tumour_staging_system": [
            "St Jude staging system"
        ],
        "recurrence_t_category": "Tis(Paget)",
        "recurrence_n_category": "N2",
        "recurrence_m_category": "M1b",
        "recurrence_stage_group": "Stage IIIBS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_6",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_2",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Distant progression",
        "relapse_type": "Local recurrence",
        "date_of_relapse": "2022-02",
        "method_of_progression_status": "Imaging (procedure)",
        "anatomic_site_progression_or_recurrence": "C14",
        "recurrence_tumour_staging_system": [
            "St Jude staging system",
            "AJCC 6th edition"
        ],
        "recurrence_t_category": "T1b(m)",
        "recurrence_n_category": "N0b (no biopsy)",
        "recurrence_m_category": "M1d",
        "recurrence_stage_group": "Stage IBES"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_7",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_3",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Partial remission",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-11",
        "method_of_progression_status": "Histopathology test (procedure)",
        "anatomic_site_progression_or_recurrence": "C19",
        "recurrence_tumour_staging_system": [
            "Rai staging system",
            "AJCC 6th edition"
        ],
        "recurrence_t_category": "Tis(DCIS)",
        "recurrence_n_category": "N2mi",
        "recurrence_m_category": "M1c(1)",
        "recurrence_stage_group": "Stage IIAE"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_8",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "submitter_treatment_id": "TREATMENT_3",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Distant progression",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-10",
        "method_of_progression_status": "Laboratory data interpretation (procedure)",
        "anatomic_site_progression_or_recurrence": "C10",
        "recurrence_tumour_staging_system": [
            "AJCC 6th edition",
            "Lugano staging system",
            "AJCC 7th edition"
        ],
        "recurrence_t_category": "Tis(DCIS)",
        "recurrence_n_category": "N1",
        "recurrence_m_category": "M1a(1)",
        "recurrence_stage_group": "Stage IEA"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_9",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
        "submitter_treatment_id": "TREATMENT_4",
        "date_of_followup": "2022-10",
        "disease_status_at_followup": "Progression not otherwise specified",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-10",
        "method_of_progression_status": "Imaging (procedure)",
        "anatomic_site_progression_or_recurrence": "C17",
        "recurrence_tumour_staging_system": [
            "International Neuroblastoma Risk Group Staging System",
            "AJCC 7th edition"
        ],
        "recurrence_t_category": "Tis(LCIS)",
        "recurrence_n_category": "N0(i+)",
        "recurrence_m_category": "M1e",
        "recurrence_stage_group": "Stage 3"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_10",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
        "submitter_treatment_id": "TREATMENT_4",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Loco-regional progression",
        "relapse_type": "Local recurrence",
        "date_of_relapse": "2022-05",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C12",
        "recurrence_tumour_staging_system": [
            "Revised International staging system (RISS)"
        ],
        "recurrence_t_category": "T2a",
        "recurrence_n_category": "NX",
        "recurrence_m_category": "M1b",
        "recurrence_stage_group": "Stage IVES"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_11",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
        "submitter_treatment_id": "TREATMENT_5",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Partial remission",
        "relapse_type": "Distant recurrence/metastasis",
        "date_of_relapse": "2021-12",
        "method_of_progression_status": "Laboratory data interpretation (procedure)",
        "anatomic_site_progression_or_recurrence": "C15",
        "recurrence_tumour_staging_system": [
            "Durie-Salmon staging system",
            "Rai staging system",
            "Lugano staging system"
        ],
        "recurrence_t_category": "Tis(Paget's)",
        "recurrence_n_category": "N0a",
        "recurrence_m_category": "MX",
        "recurrence_stage_group": "Stage IBES"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_12",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
        "submitter_treatment_id": "TREATMENT_6",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Progression not otherwise specified",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-09",
        "method_of_progression_status": "Physical examination procedure (procedure)",
        "anatomic_site_progression_or_recurrence": "C08",
        "recurrence_tumour_staging_system": [
            "St Jude staging system",
            "Lugano staging system"
        ],
        "recurrence_t_category": "T1b(s)",
        "recurrence_n_category": "N0(mol+)",
        "recurrence_m_category": "M1c",
        "recurrence_stage_group": "Stage 1A"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_13",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
        "submitter_treatment_id": "TREATMENT_7",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-04",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C09",
        "recurrence_tumour_staging_system": [
            "FIGO staging system",
            "International Neuroblastoma Staging System",
            "Rai staging system"
        ],
        "recurrence_t_category": "T2a",
        "recurrence_n_category": "N0b (no biopsy)",
        "recurrence_m_category": "M1e",
        "recurrence_stage_group": "Stage IIIAE"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_14",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
        "submitter_treatment_id": "TREATMENT_8",
        "date_of_followup": "2022-10",
        "disease_status_at_followup": "Partial remission",
        "relapse_type": "Local recurrence",
        "date_of_relapse": "2022-07",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C03",
        "recurrence_tumour_staging_system": [
            "AJCC 7th edition",
            "AJCC 8th edition",
            "FIGO staging system"
        ],
        "recurrence_t_category": "T2",
        "recurrence_n_category": "N1",
        "recurrence_m_category": "M1a(1)",
        "recurrence_stage_group": "Stage IAS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_15",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
        "submitter_treatment_id": "TREATMENT_9",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-08",
        "method_of_progression_status": "Laboratory data interpretation (procedure)",
        "anatomic_site_progression_or_recurrence": "C11",
        "recurrence_tumour_staging_system": [
            "Ann Arbor staging system",
            "AJCC 8th edition",
            "Revised International staging system (RISS)"
        ],
        "recurrence_t_category": "T2a1",
        "recurrence_n_category": "N0",
        "recurrence_m_category": "M1b(1)",
        "recurrence_stage_group": "Stage Ms"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_16",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
        "submitter_treatment_id": "TREATMENT_10",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Relapse or recurrence",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-11",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C07",
        "recurrence_tumour_staging_system": [
            "Ann Arbor staging system"
        ],
        "recurrence_t_category": "T4",
        "recurrence_n_category": "NX",
        "recurrence_m_category": "MX",
        "recurrence_stage_group": "Stage IIEB"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_17",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_5",
        "submitter_treatment_id": "TREATMENT_11",
        "date_of_followup": "2022-11",
        "disease_status_at_followup": "No evidence of disease",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-05",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C11",
        "recurrence_tumour_staging_system": [
            "International Neuroblastoma Staging System",
            "FIGO staging system"
        ],
        "recurrence_t_category": "T4b(s)",
        "recurrence_n_category": "N3",
        "recurrence_m_category": "M1e",
        "recurrence_stage_group": "Stage IIIS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_18",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_6",
        "submitter_treatment_id": "TREATMENT_12",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Biochemical progression",
        "date_of_relapse": "2022-09",
        "method_of_progression_status": "Laboratory data interpretation (procedure)",
        "anatomic_site_progression_or_recurrence": "C15",
        "recurrence_tumour_staging_system": [
            "International Neuroblastoma Staging System"
        ],
        "recurrence_t_category": "T0",
        "recurrence_n_category": "N2",
        "recurrence_m_category": "M1a(1)",
        "recurrence_stage_group": "Stage IVBE"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_19",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_7",
        "submitter_treatment_id": "TREATMENT_13",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Local recurrence",
        "date_of_relapse": "2022-10",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C15",
        "recurrence_tumour_staging_system": [
            "Lugano staging system",
            "Durie-Salmon staging system",
            "Revised International staging system (RISS)"
        ],
        "recurrence_t_category": "T4b(s)",
        "recurrence_n_category": "N0(mol-)",
        "recurrence_m_category": "M1e",
        "recurrence_stage_group": "Stage IIC"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_20",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_8",
        "submitter_treatment_id": "TREATMENT_14",
        "date_of_followup": "2022-11",
        "disease_status_at_followup": "Distant progression",
        "relapse_type": "Biochemical progression",
        "date_of_relapse": "2022-08",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C17",
        "recurrence_tumour_staging_system": [
            "Binet staging system",
            "Lugano staging system"
        ],
        "recurrence_t_category": "T0",
        "recurrence_n_category": "N1a",
        "recurrence_m_category": "M1d(0)",
        "recurrence_stage_group": "Stage III"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_21",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_9",
        "submitter_treatment_id": "TREATMENT_15",
        "date_of_followup": "2022-11",
        "disease_status_at_followup": "Partial remission",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-10",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C03",
        "recurrence_tumour_staging_system": [
            "International Neuroblastoma Risk Group Staging System"
        ],
        "recurrence_t_category": "T4a",
        "recurrence_n_category": "N0(i+)",
        "recurrence_m_category": "M1b(0)",
        "recurrence_stage_group": "Stage 4"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_22",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_10",
        "submitter_treatment_id": "TREATMENT_16",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2021-12",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C08",
        "recurrence_tumour_staging_system": [
            "AJCC 6th edition",
            "FIGO staging system"
        ],
        "recurrence_t_category": "T1a(m)",
        "recurrence_n_category": "N0(mol+)",
        "recurrence_m_category": "M1a(0)",
        "recurrence_stage_group": "Stage IIIAS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_23",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_11",
        "submitter_treatment_id": "TREATMENT_17",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Complete remission",
        "relapse_type": "Biochemical progression",
        "date_of_relapse": "2022-02",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C03",
        "recurrence_tumour_staging_system": [
            "Lugano staging system",
            "International Neuroblastoma Staging System",
            "Ann Arbor staging system"
        ],
        "recurrence_t_category": "Tis pu",
        "recurrence_n_category": "N0(i+)",
        "recurrence_m_category": "M1",
        "recurrence_stage_group": "Stage IIAS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_24",
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_12",
        "submitter_treatment_id": "TREATMENT_18",
        "date_of_followup": "2022-11",
        "disease_status_at_followup": "No evidence of disease",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-06",
        "method_of_progression_status": "Tumor marker measurement (procedure)",
        "anatomic_site_progression_or_recurrence": "C16",
        "recurrence_tumour_staging_system": [
            "Rai staging system",
            "AJCC 8th edition",
            "AJCC 7th edition"
        ],
        "recurrence_t_category": "Ta",
        "recurrence_n_category": "N1",
        "recurrence_m_category": "M0",
        "recurrence_stage_group": "Stage IVAS"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_25",
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_7",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_13",
        "submitter_treatment_id": "TREATMENT_19",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Relapse or recurrence",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2022-09",
        "method_of_progression_status": "Physical examination procedure (procedure)",
        "anatomic_site_progression_or_recurrence": "C19",
        "recurrence_tumour_staging_system": [
            "AJCC 8th edition"
        ],
        "recurrence_t_category": "T1a",
        "recurrence_n_category": "N0b (no biopsy)",
        "recurrence_m_category": "M1a",
        "recurrence_stage_group": "Stage IIC"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_26",
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_8",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_14",
        "submitter_treatment_id": "TREATMENT_20",
        "date_of_followup": "2022-08",
        "disease_status_at_followup": "Loco-regional progression",
        "relapse_type": "Distant recurrence/metastasis",
        "date_of_relapse": "2021-12",
        "method_of_progression_status": "Assessment of symptom control (procedure)",
        "anatomic_site_progression_or_recurrence": "C03",
        "recurrence_tumour_staging_system": [
            "Revised International staging system (RISS)",
            "Lugano staging system"
        ],
        "recurrence_t_category": "T4a(s)",
        "recurrence_n_category": "N3",
        "recurrence_m_category": "M0(i+)",
        "recurrence_stage_group": "Stage IIES"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_27",
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_9",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_15",
        "submitter_treatment_id": "TREATMENT_21",
        "date_of_followup": "2022-11",
        "disease_status_at_followup": "Progression not otherwise specified",
        "relapse_type": "Local recurrence and distant metastasis",
        "date_of_relapse": "2022-10",
        "method_of_progression_status": "Histopathology test (procedure)",
        "anatomic_site_progression_or_recurrence": "C15",
        "recurrence_tumour_staging_system": [
            "Lugano staging system"
        ],
        "recurrence_t_category": "T0",
        "recurrence_n_category": "N2c",
        "recurrence_m_category": "M1c(1)",
        "recurrence_stage_group": "Stage IIIA"
    },
    {
        "submitter_follow_up_id": "FOLLOW_UP_28",
        "program_id": "SYNTHETIC-2",
        "submitter_donor_id": "DONOR_10",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_16",
        "submitter_treatment_id": "TREATMENT_22",
        "date_of_followup": "2022-09",
        "disease_status_at_followup": "Stable",
        "relapse_type": "Progression (liquid tumours)",
        "date_of_relapse": "2021-11",
        "method_of_progression_status": "Physical examination procedure (procedure)",
        "anatomic_site_progression_or_recurrence": "C06",
        "recurrence_tumour_staging_system": [
            "Rai staging system",
            "International Neuroblastoma Risk Group Staging System",
            "AJCC 8th edition"
        ],
        "recurrence_t_category": "T2a2",
        "recurrence_n_category": "N0a",
        "recurrence_m_category": "MX",
        "recurrence_stage_group": "Stage IAES"
    }
]